Organigram Global Inc. (OGI)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$1.41
-2.43%
Mkt Cap $196.32M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 10, 2026 | $53.27M | $46.27M | -13.14% | -$0.01 | -$0.02 | -100.00% | — | — |
| Q4 2025 Dec 16, 2025 | $50.51M | $57.40M | +13.65% | -$0.00 | -$0.20 | -4058.00% | — | — |
| Q3 2025 Aug 13, 2025 | $73.02M | $51.96M | -28.84% | -$0.01 | -$0.03 | -200.00% | — | — |
| Q2 2025 May 12, 2025 | $65.31M | $46.06M | -29.47% | -$0.03 | -$0.05 | -66.67% | — | — |
| Q1 2025 Feb 11, 2025 | $65.27M | $29.69M | -54.51% | -$0.03 | -$0.05 | -66.67% | — | — |
| Q4 2024 Dec 18, 2024 | $52.19M | $33.09M | -36.60% | -$0.03 | -$0.04 | -33.33% | — | — |
| Q3 2024 Aug 13, 2024 | $32.24M | $30.03M | -6.85% | -$0.05 | $0.02 | +140.00% | — | — |
| Q2 2024 May 14, 2024 | $118.06M | $27.71M | -76.53% | -$0.06 | -$0.12 | -100.00% | — | — |
| Q1 2024 Feb 13, 2024 | $28.00M | $27.45M | -1.97% | -$0.10 | -$0.14 | -40.00% | — | — |
| Q4 2023 Dec 19, 2023 | $29.50M | $33.99M | +15.22% | -$0.14 | -$0.04 | +71.43% | — | — |
| Q3 2023 Jul 13, 2023 | $28.64M | $24.29M | -15.17% | -$0.05 | -$0.15 | -200.00% | — | — |
| Q2 2023 Apr 11, 2023 | $32.21M | $29.01M | -9.93% | -$0.07 | -$0.08 | -19.99% | — | — |
| Q1 2023 Jan 12, 2023 | $32.40M | $32.11M | -0.90% | -$0.01 | -$0.04 | -184.90% | — | — |
| Q4 2022 Nov 28, 2022 | $32.60M | $34.62M | +6.20% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q3 2022 Jul 14, 2022 | $26.66M | $30.23M | +13.40% | -$0.08 | -$0.12 | -50.00% | — | — |
| Q2 2022 Apr 12, 2022 | $24.98M | $25.03M | +0.21% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q1 2022 Jan 11, 2022 | $22.84M | $23.71M | +3.82% | -$0.07 | -$0.12 | -79.99% | — | — |
| Q4 2021 Nov 23, 2021 | $18.54M | $19.78M | +6.67% | -$0.16 | -$0.28 | -75.00% | — | — |
| Q3 2021 Jul 13, 2021 | $20.32M | $16.82M | -17.26% | -$0.12 | -$0.12 | +0.00% | — | — |
| Q2 2021 Apr 13, 2021 | $69.19M | $11.60M | -83.23% | -$0.12 | -$0.36 | -200.00% | — | — |